Market Cap (In USD)
15.43 Million
Revenue (In USD)
-
Net Income (In USD)
1.34 Million
Avg. Volume
3.27 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.7-5.11
- PE
- -
- EPS
- -
- Beta Value
- 0.024
- ISIN
- US03465T1088
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Joseph Sinkule Pharm.D.
- Employee Count
- -
- Website
- https://www.anewmeds.com
- Ipo Date
- Details
- Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
More Stocks
-
SRES
-
300047
-
SVRASavara Inc.
SVRA
-
SRLZF
-
NKINDN.K Industries Limited
NKIND
-
MFT
-
MAZDOCK
-
DGV